|
A Derivatization Free HPLC–UV Method for Nitrite Quantification in Strongly Matrix-Affected Pharmaceutical Excipients-Pub「
|
|
3
|
271
|
September 5, 2026
|
|
Efficacy of ultraviolet irradiation of pharmaceutical excipients in mitigating N-nitrosamine generation-Pub
|
|
4
|
403
|
September 1, 2026
|
|
Establishing a Robust High Performance Liquid Chromatography−Ultraviolet Detection Technique for Nitrite Quantification in Pharmaceutical Excipients and Active Pharmaceutical Ingredients-Pub
|
|
0
|
147
|
August 22, 2026
|
|
MEGLUMINE (Methylglucamine)
|
|
31
|
4577
|
July 20, 2026
|
|
Determining Low PPB Levels of Nitrite in Polymeric Excipients
|
|
2
|
430
|
July 19, 2026
|
|
Analytical Challenges in Quantifier Ion Selection Due to Mass Error Variability
|
|
7
|
386
|
July 2, 2026
|
|
Understanding In Vitro Nitrosamine Formation During Sample Preparation
|
|
4
|
349
|
June 1, 2026
|
|
Nitrite in Amines
|
|
14
|
1187
|
May 21, 2026
|
|
Liquid Chromatography–High-Resolution Mass Spectrometric Determination of Nitrite Ion Concentration in the Natural Water Resources -Pub
|
|
0
|
109
|
May 20, 2026
|
|
Excipient Selection Strategies to Mitigate Nitrosamine Risks
|
|
0
|
275
|
April 8, 2026
|
|
Optimized UHPLC–Derivatization Method for Low-Level Nitrite Detection in Pharmaceutical Excipients-Pub
|
|
0
|
264
|
March 23, 2026
|
|
Impact of post approval quantitative changes in excipient composition on nitrosamine formation: De-risking strategy-Pub
|
|
0
|
159
|
March 23, 2026
|
|
Nitrites/Nitrosamines: The impacts on analytics, but not only
|
|
0
|
206
|
February 17, 2026
|
|
Nitrosamine Impurities: The Analytical & Regulatory Roadmap (2024-2025)
|
|
0
|
491
|
January 20, 2026
|
|
Nitrosamine Impurities in Excipients
|
|
11
|
687
|
January 8, 2026
|
|
Nitrites in Excipients
|
|
7
|
651
|
November 28, 2025
|
|
IPEC Excipient new questionnaire, October 2025
|
|
1
|
308
|
October 23, 2025
|
|
Updated: IPEC Questionnaire for Excipient Nitrosamines Risk Evaluation
|
|
2
|
795
|
October 23, 2025
|
|
Nitrite testing in Excipients
|
|
2
|
722
|
August 17, 2025
|
|
Nitrosamines excipient EDTA
|
|
3
|
527
|
June 12, 2025
|
|
Interferencia de matriz para cuantificación de NDBA
|
|
0
|
92
|
May 5, 2025
|
|
Can Ionized Air in Pharma Pose a Risk of Nitrite Formation
|
|
4
|
553
|
March 10, 2025
|
|
Impact of Antioxidant Excipients on N-nitrosamine Formation and Bioequivalence in Metformin Formulations - Pub
|
|
3
|
904
|
February 11, 2025
|
|
Low nitrite excipients
|
|
11
|
3371
|
November 27, 2024
|
|
Nitrosamnes in PMs & Excipients Questions
|
|
5
|
1164
|
November 22, 2024
|
|
Managing Nitrite Impurities: A Supplier-Manufacturer Approach to Mitigate Nitrosamine Risk
|
|
2
|
763
|
October 18, 2024
|
|
Primeros pasos para evaluar nitrosaminas en medicamentos
|
|
5
|
502
|
September 23, 2024
|
|
Potential Topic for an event concerning obtaining the right level of Nitrosamine Risk Assessment information from your CMOs
|
|
21
|
2064
|
September 5, 2024
|
|
4-(nitroso(vinyl)amino)butanoic acid from Kollidon?
|
|
7
|
677
|
August 29, 2024
|
|
IPEC Webinar on the role of excipients in determine N-nitrosamine risks
|
|
3
|
523
|
July 24, 2024
|